China Ophthalmic Service Market Size By Type (Public, Private), By Application (Clinics, General Hospital), And Forecast

China Ophthalmic Service Market Size And Forecast

China Ophthalmic Service Market size was valued at USD 1.12 Billion in 2024 and is projected to reach USD 1.64 Billion by 2031, growing at a CAGR of 4.9% from 2024 to 2031. The rise in people suffering from common visual disorders such as myopia, cataract, and glaucoma is driving the China Ophthalmic Service Market. A growing aging population and rising purchasing power also fueling the growth of the China Ophthalmic Service Market. The China Ophthalmic Service Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

China Ophthalmic Service Market Definition

Ophthalmic service refers to the diagnosis, treatment, and prevention of disorders of the visual system and diseases of the eyes. These services include treatments through therapy, medications, and surgeries (micro as well as macro). Most visual disorders such as cataracts, myopia, glaucoma, macular degeneration, strabismus, uveitis, and others, can be diagnosed and treated with the application of ophthalmic services. The most common visual disorders are myopia, hypermetropia, and cataract. Eye drops, eye lotion, eye ointment, eye suspensions, and contact lenses with solution are among the many eye products provided by an ophthalmologist for the treatment of eyes before and after surgery.

The quality of eye care in China varies widely by region and between urban and rural areas. About 75% of primary care for eye problems is provided by small local clinics. Advanced ophthalmology treatment is excessively skewed in urban Class III hospitals. The majority of inpatients at large urban hospitals are from nearby rural areas, with 30% to 50% seeking a second or third opinion. The Chinese government wants to promote reforms that would allow lower-level hospitals to perform more advanced diagnostics and treatments.

China ophthalmic services providers offer general medical and surgical hospital services. It offers ophthalmic health care, diagnosis, treatment, surgical treatment services, and the sale of visual aid and pharmaceutical products in China. The players offer cataract, cornea, and ocular surface diseases, glaucoma, vitreoretinal and macular diseases, other eye diseases diagnosis and treatment services, and Chinese medicine treatment of eye diseases. They generate a vast majority of their revenue from the provision of the ophthalmic services segment.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

China Ophthalmic Service Market Overview

China's ophthalmic service offers secure and efficient treatments for all visual disorders. The rise in people suffering from common visual disorders such as myopia, cataract, and glaucoma is driving the China Ophthalmic Service Market. New trends and developments in technologies related to the adoption of contact lenses, and laser treatments, are driving the growth of the market. A growing aging population and rising purchasing power also fueling the growth of the China Ophthalmic Service Market.

However, there are some side effects viz. headache, runny or stuffy nose, sore throat, and rest, of the ophthalmic medication might restrain the China Ophthalmic Service Market. There are some other factors such as the high cost of the services and the ophthalmic equipment and surgical instruments that might challenge the market. Furthermore, In China, ophthalmic ultrasound and related technology have experienced rapid growth. The increasing patient count for eye illnesses will be a direct result of China's 1.4 billion population aging. This offers a lucrative growth opportunity for the China Ophthalmic Service Market expansion.

China Ophthalmic Service Market Segmentation Analysis

The China Ophthalmic Service Market is segmented on the basis of Type And Application.

China Ophthalmic Service Market, By Type

• Public
• Private

Based on Type, The market is classified into Public and Private. The Public windshield has the majority of the market share. The public segment is expected to grow during the forecasted years.

China Ophthalmic Service Market, By Application

• Clinics
• General Hospital
• Specialty Hospital
• Others

Based on Application, The market is classified into Clinics, General Hospital, Specialty Hospital, and Others. Specialty Hospital is expected to grow at a significant rate during the forecasted years.

Key Players

• The "China Ophthalmic Service Market" study report will provide valuable insight with an emphasis on the market including some of the major players such as
• C-MER Eye Care, Shin Nippon Biomedical Laboratories Ltd., Topcon Corporation, and ZEISS.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players.

Key Developments

• In January 2020, C-MER Eye Care Holdings Ltd. of Hong Kong stated on Thursday that it had secured a land plot in Pingshan District for 209 million yuan (US$30 million). In the Guangdong-Hong Kong-Macao Greater Bay Area, the parcel will be turned into a high-end eye hospital and C-MER's headquarters.